pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
723
stories
5d
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
fiercebiotech
5d
Senator-elect Abdul El-Sayed on restoring trust in science, the state of public health, and RFK Jr.
stat
6d
Virtuoso Surgical nabs FDA authorization for robotic bladder lesions system
fiercebiotech
6d
Sanofi-backed Windward hits $225M IPO goal, as Rezera delays listing over ‘market conditions’
fiercebiotech
6d
Windward prices $175M IPO to advance China-licensed lung drugs
biopharma dive
6d
Bristol Myers research chief to depart in ‘evolution’ of company’s structure
biopharma dive
6d
Chutes & Ladders—Bristol Myers' research chief out amid R&D reorganization
fiercebiotech
7d
Valo and Montai become one as the Flagship AI-based biotechs tie the knot
fiercebiotech
7d
BioNTech pays $205M for FDA voucher to speed up ‘late-stage oncology pipeline’
fiercebiotech
8d
Beam preps FDA run for industry-first base-edited therapy after pivotal sickle cell success
biospace
8d
Why this year’s flu season could be hitting teens and young adults hard
stat
8d
Opinion: AI’s health advice can be accurate and still make us sicker
stat
9d
Novocure denied FDA approval for Optune Mya cancer device after efficacy concerns
fiercebiotech
9d
Liver experts finally agree on what acute-on-chronic liver failure is
stat
9d
Sanofi-backed Windward breezes toward $204M IPO to fund respiratory pipeline from China
fiercebiotech
9d
Kyorin pens $140M deal for Japan rights to Edesa’s phase 3 respiratory drug
fiercebiotech
11d
Could we see 10 Chinese Big Pharmas within a decade? Some CEOs think so
fiercebiotech
12d
J&J’s Rybrevant nets FDA approval in head and neck cancer
endpoints
12d
Moderna enjoys stable vaccine sales thanks to global COVID uptake
biospace
12d
‘Cancer hasn't seen this molecule before’: Onchilles’ injection shows potential for solid tumors
fiercebiotech
12d
Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November
biospace
12d
Merck, Moderna serve 99% of trial patients with mRNA vaccine as personalized shots near market
biospace
13d
Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter
fda recalls
13d
FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
fda press
13d
Medicare will cut billions from 340B, expand site-neutral payments in 2027
biopharma dive
13d
At ASH, drugmakers to showcase early data for three-pronged cancer therapies
biopharma dive
13d
RevMed’s Rasonque shatters analyst estimates with $198M quarter
biospace
13d
Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZeneca
biospace
14d
Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’
biospace
14d
Boehringer returns to Sino Biopharma in $7.4B deal for preclinical TCEs, ADCs
fiercebiotech
← prev
page 2 of 25
next →